0001828318False00018283182025-06-122025-06-12

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 12, 2025
Enovix Corporation
Capture.jpg
(Exact Name of Registrant as Specified in Its Charter)
 
Delaware001-3975385-3174357
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
3501 W Warren Avenue
Fremont, California
 94538
(Address of Principal Executive Offices) (Zip Code)
Registrant’s Telephone Number, Including Area Code: (510) 695-2350
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading
Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.0001 per shareENVXThe Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 5.07 Submission of Matters to a Vote of Security Holders.
On June 12, 2025, Enovix Corporation (the “Company”) held its 2025 Annual Meeting of Stockholders (the “Annual Meeting”). Present at the Annual Meeting in person or by proxy were holders of 129,481,579 shares of the Company’s common stock, representing 67.5% of the voting power of the Company’s common stock as of April 15, 2025, the record date for the Annual Meeting, and constituting a quorum for the transaction of business. At the Annual Meeting, the Company’s stockholders voted on three proposals, each of which is described in more detail in the Company’s definitive proxy statement filed with the U.S. Securities and Exchange Commission (the “SEC”) on April 24, 2025 (the “Proxy Statement”). The following is a brief description of each matter voted on at the Annual Meeting, including the number of votes cast with respect to each matter and, if applicable, the number of abstentions and broker non-votes with respect to each matter.
Proposal 1 – Election of Directors
Stockholders approved the election of each of the Company’s seven (7) directors to serve for a one-year term until the Company’s 2026 Annual Meeting of Stockholders. The results of the voting were as follows:
NomineeVoting ResultForWithheldBroker Non-Votes
Thurman John RodgersApproved64,473,8607,720,71557,287,004
Betsy AtkinsApproved51,590,39720,604,17857,287,004
Pegah Ebrahimi
Approved70,612,9011,581,67457,287,004
Bernard GutmannApproved70,853,4151,341,16057,287,004
Joseph MalchowApproved70,339,9831,854,59257,287,004
Gregory ReichowApproved67,213,9614,980,61457,287,004
Dr. Raj TalluriApproved71,299,102895,47357,287,004
Proposal 2 – Compensation of Our Named Executive Officers
Stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement. The results of the voting were as follows:
Voting ResultForAgainstAbstainBroker Non-Votes
Approved55,047,45216,563,470583,65357,287,004
Proposal 3 – Ratification of Appointment of Independent Registered Accounting Firm for Fiscal Year 2025

Stockholders approved the ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 28, 2025. The results of the voting were as follows:
Voting ResultForAgainstAbstain
Approved126,196,4811,913,6231,371,475





SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
   Enovix Corporation
    
Date:
June 16, 2025
By:
/s/ Arthi Chakravarthy
Arthi Chakravarthy
Chief Legal Officer and Head of Corporate Development